VIDI Grant for a microchip-based toolbox to treat osteoporosis

Monday, 18 February 2019

Radboudumc researcher Alireza Dolatshahi-Pirouz, partner of hDMT, received a VIDI Grant of 800,000 euros to develop his innovative research project on regenerative biomaterials and to build up his own research group. VIDI will allow him to conduct research for a period of five years.

Due to the aging population new innovations are needed to treat osteoporosis, the most common disability among today's elderly. Regenerative medicine can address this challenge through hydrogel-based stem cell therapies. The goal of Alireza is to develop a microchip-based toolbox to test thousands of such therapies in a single experiment.

Specifically, he plans to use this toolbox for screening of combinatorial biomaterials with the capacity to turn stem cells into osteoblasts within mechanically reinforced, bone regenerative and self-healable hydrogels that are exposed to cyclic load-bearing forces reminiscent of those found in the human bone. The proposed toolbox could lead to an accelerated discovery of combinatorial stem cell therapies to treat osteoporosis.

NWO (The Netherlands Organisation for Scientific Research) is awarding the VIDI Grants as part of the Innovational Research Incentives Scheme. VIDI is aimed at excellent researchers who have been producing successful research for a number of years since obtaining their PhD. These academics are among the best 10 to 20 percent in their field.

Back to the news overview